Gatitrip B Eye Drops contain Benzalkonium Chloride 0.005% w/v and Gatifloxacin 0.3% w/v, a combination designed to treat bacterial eye infections effectively. It helps in reducing redness, irritation, and bacterial proliferation, promoting faster ocular recovery.
Gatifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing bacterial replication. Benzalkonium Chloride acts as a preservative with additional antimicrobial properties, maintaining sterility and enhancing efficacy.
Clinically, Gatitrip B Eye Drops are indicated for bacterial conjunctivitis, keratitis, and other superficial ocular infections. The formulation allows accurate dosing, rapid ocular absorption, and patient-friendly administration, ensuring effective treatment outcomes.
Regular use under medical supervision helps in resolving infection, reducing inflammation, improving ocular comfort, and preventing complications. Gatitrip B Eye Drops is a trusted antibacterial ophthalmic therapy, providing reliable management of bacterial eye infections.